Venus gets market authorisation from Swiss drug authority

Tags: Companies
Pharma major Venus Remedies has secured its first marketing authorisation in Switzerland from Swiss drug authority 'Swissmedic' for its oncology drug 'Gemcitabine'.

The marketing approval for Gemcitabine will help the company further strengthen its oncology portfolio and improve its presence in this space, Venus Remedies said in a statement here today.

The Panchkula-based company plans to launch the drug early next quarter and the product will be launched in Switzerland by Swiss Pharma GmbH, with which Venus has a marketing tie-up, it said.

"The launch of this product will add to the company's top line and bottom line in the coming quarters," it said.

Venus Remedies has already received more than 20 marketing approvals for Gemcitabine injection from various countries. The product is being sold in the UK, Poland and Germany.

Gemcitabine is an anti-cancer drug used for the treatment of a variety of cancerous conditions, including the cancer of the lungs, pancreas, bladder and breast.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Salman should be punished for what he did and not for who he is

    Salman Khan is a Bollywood phenomenon. On the professional front, he can do no wrong.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Simon J Evenett

Trade policy: more heat than light?

After several years in the doldrums, trade policy is back. ...

Zehra Naqvi

Happy people are better workers

We know that the state of mind we are in ...

Dharmendra Khandal

Tales from the dry, deciduous forest of Kuno

Kuno is an incredibly dry deciduous (dhonk) tree forest of ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture